Satiety signalling (revision 6)
Old revision·18:04, 14 Oct 2024·LabRangeLindy
| Satiety signalling | |
|---|---|
| Satiation | Termination of a meal in progress |
| Satiety | Suppression of intake between meals |
| Principal relay | Nucleus of the solitary tract, area postrema |
| Topic infobox · conventions | |
Satiety signalling comprises the peripheral signals and central circuits that end a meal and delay the next one. The literature distinguishes satiation — the process terminating an eating episode — from satiety, the inter-meal suppression of appetite; the distinction matters because different signals dominate each.[1]
Peripheral signals include gastric distension relayed by vagal mechanoreceptors, nutrient-sensing hormones from the small intestine such as cholecystokinin, GLP-1, peptide YY and amylin, and longer-term adiposity signals such as leptin and insulin. These converge on the caudal brainstem and on hypothalamic circuits including the arcuate nucleus.[1]
Pharmacological exploitation of this system is what GLP-1 receptor agonists do. They produce a sustained supraphysiological signal in a system evolved for episodic signalling, and the great majority of the weight loss they produce is attributable to reduced energy intake rather than to increased expenditure.[2]
Peripheral signals
[edit]Gastric distension is the most immediate satiation signal, relayed by vagal afferents in the stomach wall. It is volume-dependent rather than calorie-dependent, which is why delayed gastric emptying produces satiation out of proportion to the nutrient consumed.[1]
Intestinal hormones add nutrient specificity. Cholecystokinin is released from duodenal I cells in response to fat and protein and acts largely within a meal. GLP-1 and peptide YY are released from more distal L cells and act over a longer window. Amylin, co-secreted with insulin from the pancreas, acts at the area postrema.[3]
Adiposity signals set the background against which meal-related signals are read. Leptin and insulin circulate in proportion to fat mass and modulate the sensitivity of the hypothalamic circuits to meal-related input rather than terminating meals themselves.[4]
References
- ^ a b c Woods SC. "The control of food intake: behavioral versus molecular perspectives." Cell Metabolism 9(6):489–498 (2009). DOI:10.1016/j.cmet.2009.04.007. PMID 19490904.
- ^ Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." Cell Metabolism 27(4):740–756 (2018). PMID 29617641.
- ^ Holst JJ. "The physiology of glucagon-like peptide 1." Physiological Reviews 87(4):1409–1439 (2007). PMID 17928588.
- ^ Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. "Central nervous system control of food intake." Nature 404(6778):661–671 (2000). DOI:10.1038/35007534. PMID 10766253.